Finoriq research workspace
Advanced Biomed Inc. (ADVB) SEC Filings & Filing Highlights
Advanced Biomed Inc., an investment holding company, engages in the research and development of. Review ADVB SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, an automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cell (CTC) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product. The company also offers microfluidic biochips, such as A+Pre, AC-1000 CTC enrichment, and A+CellScan chips to provide assay products and services to cancer patients. In addition, its immunochromogenic kits include A+CTCE kit to identify epithelial circulating tumor cells and determined by the immunochromogenicity of EpCAM, CK (pan), CD45, and CD14 antibodies; A+CTCM kit to identify mesenchymal circulating tumor cells based on the immunochromogenicity of Vimentin, CD45, and CD14 antibodies; A+EMT to identify epithelial-to-mesenchymal circulating tumor cells determined by the immunochromogenicity of cell-surface Vimentin, and CD45 and CD14 antibodies; and A+CM to identify tumor-associated macrophages based on the immunochromogenicity of PD-L1, CD45, and CD14 antibodies. Further, the company is developing A+LCGuard for early screening of lung cancer. Additionally, it establishes and operates medical clinics in the People's Republic of China. The company was founded in 2014 and is headquartered in New York, New York.
- Company
- Advanced Biomed Inc. (ADVB)
- Ticker
- ADVB
- Market Cap
- $14.7M
- Latest Price
- $8.8999
- Industry
- Medical Devices
Advanced Biomed Inc. (ADVB) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Advanced Biomed Inc. (ADVB).
| Event | Form | Date |
|---|---|---|
| Against / WithheldOn June 30, 2026, at 10:00 a.m. Eastern Time, Advanced Biomed Inc. (the “Company”) held its annual meeting of stockholders (the “Meeting”)... | 8-K5.07 | 2026-07-01 |
| Advanced Biomed Inc.: Material agreementOn June 30, 2026, Advanced Biomed Inc. (the “Company”) entered into a Share Purchase Agreement (the “Agreement”) with an unrelated third pa... | 8-K1.01 | 2026-06-30 |
| The Company has determined to undertake a significant strategic pivot, transitioning its primar...The Company has determined to undertake a significant strategic pivot, transitioning its primary business focus from life sciences to artif... | 8-K5.02 | 2026-05-01 |
| Advanced Biomed Inc.: Securities issuanceThe information under Item 2.01 of this Current Report on Form 8-K related to the issuance of 270,000 shares of the Company’s common stock... | 8-K3.02 | 2026-05-01 |
| Advanced Biomed Inc.: Acquisition or asset dispositionAs reported on the Current Report on Form 8-K of Advanced Biomed Inc. (the “Company”) filed with the SEC on April 3, 2026, the Company ente... | 8-K2.01 | 2026-05-01 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.